Sort by
Refine Your Search
-
Listed
-
Category
-
Country
- United States
- Germany
- United Kingdom
- Denmark
- France
- Belgium
- Spain
- Austria
- Worldwide
- Mexico
- India
- South Africa
- Canada
- Sweden
- Switzerland
- United Arab Emirates
- Italy
- Luxembourg
- Netherlands
- Singapore
- Turkey
- Australia
- Hong Kong
- Finland
- Ireland
- Argentina
- Japan
- Malaysia
- Norway
- Poland
- Portugal
- South Korea
- Taiwan
- Vietnam
- 24 more »
- « less
-
Program
-
Field
-
to genomic and metabolomic data processing and analysis within the Advanced Technology & Genomics (ATG) core, including software pipelines for short-read and long-read-based genome sequencing, single-cell
-
PhD in medical physics, engineering, or related physical science. Applicants should hold a PhD in medical physics, engineering, or related physical science. Certification in radiation oncology physics
-
operational excellence of our core technology platforms supporting cutting-edge research across the center. The postholder consults and reports directly to HZI management. Your Responsibilities: Management and
-
July 1, 2026. Interested candidates may contact: Trachia Wilson, C-TAGME, CAP | Fellowship Program Coordinator Pediatric Infectious Diseases | St. Jude Children's Research Hospital Email: [email
-
minimum of two years of postdoctoral experience is required. Successful candidates are expected to establish a vigorous research program and contribute to the department’s teaching mission. Applicants with
-
Industrial Efficiency: Access to shared resources and facilities led by expert scientists, coupled with cutting-edge technology, accelerates research productivity. Customized Professional and Career Growth
-
computer software; Assisting with preparing grant applications to secure further funding for relevant projects; Helping establish new projects and research consortia relating to the Zuccolo Group research
-
, optical physics, atomic and molecular physics, plasma physics, soft matter physics, and condensed matter theory and computational physics. There are 12 laboratories and 8 centers in our research system
-
have developed a range of genetic engineering strategies to modify EVs for the purpose of drug delivery. In addition to EVs, the EL Andaloussi lab also engineers various conjugates for extrahepatic
-
state-of-the-art computational and high-throughput experimental validation methods in functional, de novo protein design. Over the next two years, the team will jointly develop computational methods